CNS Embryonal Tumour With PLAG Family Gene Alteration: Failure of Response to RET Inhibition
Neuropathology and Applied Neurobiology · 2026-04 · 52 (2)
DOI: 10.1111/nan.70076 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropathology and Applied Neurobiology, online erschienen am 15.04.2026. Verfasst von David King und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Oncology, Sheffield Children's Hospital, Sheffield, UK. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
A rare central nervous system (CNS) embryonal tumour characterised by alterations in the PLAG family gene has recently been reported. RET is a direct PLAGL1/2 target and RET inhibitors were thought to have therapeutic potential in this tumour. In a patient with a CNS tumour with PLAGL2 amplification, we show RET inhibition had no clinical effect. Transcriptomic profiling demonstrated low RET levels with associated low levels of RET phosphorylation (pRET). Measurement of RET/pRET activity may be useful in predicting response to RET inhibition in these tumours.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Paediatric Oncology, Sheffield Children's Hospital, Sheffield, UK.
- Department of Molecular Life Sciences, School of Life Sciences, Technical University of Munich, Freising, Germany.
- German Cancer Consortium (DKTK), Partner Site Munich, a Partnership Between DKFZ and University Medical Center Munich, Germany.
- Bavarian Cancer Research Center (BZKF), Munich, Germany.
- Division of Pediatric Glioma Research, Hopp Children's Cancer Center Heidelberg, (KiTZ), Heidelberg, Germany.
- National Center for Tumour Diseases (NCT), NCT Heidelberg, a Partnership Between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.
ORCID-Profile: David King, Michaela-Kristina Keck
Zitieren
APA
King, D., Schneider, A., Küster, B., Jones, D. T. W., Connolly, D. J. A., Wharton, S., & Keck, M. K. (2026). CNS Embryonal Tumour With PLAG Family Gene Alteration: Failure of Response to RET Inhibition. Neuropathology and Applied Neurobiology, 52(2). https://doi.org/10.1111/nan.70076
Vancouver
King D, Schneider A, Küster B, Jones DTW, Connolly DJA, Wharton S, et al. CNS Embryonal Tumour With PLAG Family Gene Alteration: Failure of Response to RET Inhibition. Neuropathology and Applied Neurobiology. 2026;52(2). doi:10.1111/nan.70076
BibTeX
@article{King2026,
author = {King, David and Schneider, Annika and Küster, Bernhard and Jones, David T W and Connolly, Daniel J A and Wharton, Stephen and Keck, Michaela-Kristina},
title = {CNS Embryonal Tumour With PLAG Family Gene Alteration: Failure of Response to RET Inhibition},
journal = {Neuropathology and Applied Neurobiology},
year = {2026},
volume = {52},
number = {2},
doi = {10.1111/nan.70076}
}
EUVIMED